RBR-4zsh6g8
Recruiting
未知
Prevention of drug-induced jaw Osteonecrosis in oncological patients undergoing Exdontics – randomized clinical trial
Sociedade Pernambucana de Combate ao Câncer0 sitesApril 3, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Bisphosphonate-Associated Osteonecrosis of the Jaw
- Sponsor
- Sociedade Pernambucana de Combate ao Câncer
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients over 18 years of age; both genders; presence of teeth requiring simple extraction; patient submitted to medications that induce osteonecrosis of the jaw for antineoplastic treatment
Exclusion Criteria
- •Patients who underwent radiotherapy treatment in the head and neck region; patient diagnosed with metastasis in gnathic bones; patients with any known contraindications or allergies to methylene blue or some of the prescribed medications; patients with any clinical impediment to performing photobiomodulation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Treatment of Medication-related osteonecrosis of the jaw: a clinical examinatioM87.18DRKS00009411Klinik für Mund-, Kiefer- und Gesichtschirurgie200
Completed
Not Applicable
Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic AcidOsteonecrosis of the JawInfection Leading to HospitalizationNCT01967160Amgen2,560
Unknown
Not Applicable
Initial Management of MRONJ Stages I and II, a Clinical Trial With Detection of Salivary BiomarkersOsteonecrosis of the Jaw, Bisphosphonate InducedOsteonecrosis of the Jaw, Bisphosphonate RelatedNCT04584840Fundació d'investigació Sanitària de les Illes Balears50
Recruiting
Not Applicable
Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive DrugsOsteonecrosis of the JawOsteonecrosis Due to Drugs, JawOsteonecrosis Due to DrugBisphosphonate-Associated OsteonecrosisBisphosphonate-Associated Osteonecrosis of the JawNCT06457776Catholic University of the Sacred Heart126
Recruiting
Not Applicable
A study on the prevention of exacerbation of oral mucositis by early initiation of Episil oral liquid in hematopoietic stem cell transplant recipients and head and neck cancer patientsHead and neck cancer, Hematological malignancyJPRN-UMIN000045409Fujita Health University90